CTOs on the Move

Valley Health System

www.valleyhealthcareers.com

 
Valley Health System is a regional healthcare system that serves residents in northern New Jersey and southern New York. It comprises The Valley Hospital, Valley Home Care and Valley Medical Group. Key services include cardiology, oncology, women’s and children’s services, emergency care, orthopedics and neurosciences. Valley Health System’s Centers of Excellence offer comprehensive coordinated inpatient and outpatient programs and services to help ensure excellent clinical outcomes and quality. The Centers of Excellence include Cardiac/Heart Failure, Diabetes, Oncology, Pulmonary, Geriatrics, Total Joint and Neurovascular. Valley maintains affiliations and collaborations with Mount Sinai Health System and with Cleveland Clinic’s Sydell and Arnold ...
  • Number of Employees: 1K-5K
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Hallmark Palm Springs

Hallmark Palm Springs is a Palm Springs, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Labyrinth Health Care Group

Labyrinth Health Care Group is a Milwaukee, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

The F. Dohmen Co.

The F. Dohmen Co. is a fifth-generation, family-owned business, which has been serving the healthcare industry for over 145 years.

Care Medical

Care Medical is a Maumelle, AR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cleveland Biolabs

Cleveland BioLabs, Inc. (NASDAQ: CBLI) is an innovative bio pharmaceutical company developing novel approaches to activate the immune system and address serious medical needs. Our proprietary platform of toll-like immune receptor activators has applications in radiation mitigation, oncology immunotherapy, and vaccines. We combine our proven scientific expertise and our depth of knowledge about our products’ mechanisms of action into a passion for developing drugs to save lives. Our proprietary drug candidates act via unique mechanisms that are designed to kill cancer and protect healthy cells. Our most advanced product candidate is entolimod, which we are developing as a radiation countermeasure and an immunotherapy for oncology and other indications. We have additional pipeline product candidates in various stages of development.